As described in previous chapters, a growing body of evidence supports the clinical utility of ketamine in major depression. A smaller body of evidence suggests utility in other disorders, including obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and alcohol/substance use disorders. This chapter reviews the available data and suggests new avenues for research.
CITATION STYLE
Rodriguez, C. I., & Dakwar, E. (2016). Emerging data for ketamine in obsessive-compulsive, stress-related, and substance use disorders. In Ketamine for Treatment-Resistant Depression: The First Decade of Progress (pp. 137–155). Springer International Publishing. https://doi.org/10.1007/978-3-319-42925-0_9
Mendeley helps you to discover research relevant for your work.